Anxiety Disorders Terminated Phase 3 Trials for Escitalopram (DB01175)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric PatientsTreatment
NCT00114374SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma VictimsPrevention